Overview

Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy and safety of repeated administration of adalimumab in adult Japanese subjects with moderate to severe chronic plaque psoriasis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Abbott
Collaborator:
Eisai Limited
Treatments:
Adalimumab
Antibodies
Antibodies, Monoclonal